top of page

Libido

  • Low libido is not distressing to everyone. Testosterone does not need to be prescribed if levels are low but distress is not present.
  • HSDD is multi-factorial. Best practice is to excluded relationship difficulties, psychological trauma, dyspareunia and vulvovaginal atrophy. Consider medications e.g. SSRIs and SNRIs as a possible cause.
  • When treating low sexual desire /arousal it is also important that urogenital tissues are adequately estrogenised in women with
  • vulvovaginal atrophy / genitourinary syndrome of the menopause e.g. through use of vaginal estrogen, to avoid dyspareunia
  • Oral estrogens, especially conjugated estrogens can reduce the effectiveness of testosterone by increasing the SHBG levels. Consider switching women with HSDD from oral to transdermal estrogens can be beneficial.
  • Patients should be informed that this is a commonly prescribed but off- licence treatment.
  • Side effects or adverse effects are uncommon as long as levels are kept within the female physiological range.
  • Testosterone replacement is for patients in menopause, both natural and surgical. There is very little data for testosterone replacement in premenopausal women which remains a controversial area requiring more research.
bottom of page